Since, ACE inhibitors (Angiotensin Converting enzyme inhibitors) like Captopril have reportedly shown a cardiac beneficial role after coronary event but there is no such study which has ruled out its efficacy among different age groups. So this study aim was to rule out the effect of aging and efficacy of Captopril among Chinese cardiovascular patients with acute myocardial infarction (MI) during the hospitalization phase of therapy.
Abstract Background
Since, ACE inhibitors (Angiotensin Converting enzyme inhibitors) like Captopril have reportedly shown a cardiac beneficial role after coronary event but there is no such study which has ruled out its efficacy among different age groups. So this study aim was to rule out the effect of aging and efficacy of Captopril among Chinese cardiovascular patients with acute myocardial infarction (MI) during the hospitalization phase of therapy.
Method
Randomized study was conducted at Tongji Medical College Hospital with recruitment of 100Chinese patients, mean age64 ±10years with53%males.All presented with first time acute MI and received standard conventional therapy, including intravenous-thrombolysis ,oral aspirin with beta blocker.Later,they were randomly divided to Captopril-STUDY group and Conventional therapy-CONTROL group and were further subdivided in 4groups depending on age. Statistical analyses were done to formulate the correlation between multi-variables.
Results
Systolic blood pressure in 60 patients receiving Captopril was significantly lower than in 40 patients who got the conventional therapy only (135.6 ±14.4mmHg/82.8 ±10.3mmHg vs. 144.1 ±18.8mmHg/83.2 ±11.3mmHg, P<0.05). Overall 4 patients in the study group and 9 patients in control group died within the hospital (6.67% vs. 22.5%, P<0.0001).Careful data analysis proved that the survival of patients on Captopril correlated significantly with age (P<0.001). Patient's survival was statistically significant with respect to age (P<0.001).Survival rate was better among elderly on Captopril in comparison to younger ones during the hospitalization. Other significant multivariates were smoking, ejection fraction beta-blocker use, cardiac enzyme levels and the intravenous thrombolysis.
Conclusion
Survival with Captopril is more in elderly Chinese patients then young reflecting that ACE-inhibitors in proper dosage play a real beneficial role among elderly after acute MI. thus exhibiting many beneficial effects. Cardiac rehabilitation phase is the key in determining the future prospects ,and making a probability about upcoming cardiac problems and among patients with acute myocardial infarction, it is usually divided primarily to hospitalization phase(phase 1-inpatient) and follow-up phase(phase 2 and 3 Phase 2 -Outpatient Programme (from hospital discharge to 12 weeks) .Phase 3 -Maintenance Programme (ongoing, to maintain health gains, cardiac club) of rehabilitation lasting usually up to 6 months from the day of infarction 14 . Among patients with first time myocardial infarction event, age may be a powerful independent indicator of mortality rate within the hospital, age-related increase in the mortality rate cannot be explained by large Medications and cardiac events including congestive cardiac failure, fatal arrhythmias, reinfarction and sudden cardiac deaths were continuously monitored among all these groups. Severe arrhythmias like ventricular tachycardia, flutter or fibrillation, sinus arrest, sinoatrial block and complete atrio-ventricular blocks were specifically focused in the trial. Significant pathological coronary arterial stenosis (above 70% luminal diameter) was assessed by arteriography.Ejection fraction (EF) was measured by twodimensional echocardiography. The two main groups and four subgroups were statistically compared by using ANOVA, Chi-square and Student't test. Variables affecting the efficacy of Captopril were defined in terms of age, sex,familial predisposition, smoking, hypertension, diabetes mellitus,hyperlipidemias,renal diseases, peak Creatanine phosphate kinase (CPK-MB)/troponin T levels,LV ejection fraction , timing of infarct, site of infarction, thrombolytic therapy, beta-blocker, and antiplatelet drugs. All the analyses were performed statistically and a probability (P) of <0.05 was considered significant.
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Results
Systolic blood pressure in 60 patients receiving Captopril was significantly lower than in 40 patients( Table 1 and  Table 2 were smoking (P<0.01), beta-blocker (P<0.005), peak CPK (P 0.005), and the intravenous thrombolysis (P 0.01). 
Discussion
Our study clearly reflected that the early effects of Captopril treatment among patients with acute myocardial infarction definitely varied with respect to age. Captopril has a minor effect on younger patients (60 years old and less) and an extremely beneficial effect on elderly patients (60-70 years old) during the hospitalization. On one side, the overall survival rate was lower among elderly patients than that of younger ones in hospitalization phase regardless of the fact, whether Captopril was taken or not. But the most significant finding is that the increased survival after taking Captopril was higher in elderly patients than in younger patients. Captopril protects the ischemic and infarcted zone of injured myocardium after the myocardial infarction and markedly enhances the survival of old aged patients. Treatment with Captopril is definitely associated with improved short as well as long term cardiac prognosis and markedly. Captopril therapy is associated with improved long term prognosis and reduced cardiac mortality during the hospitalization phase of the therapy and recovery period.
Beta-blockers like metoprolol also enhance its efficacy and beneficial effects. Captopril decreases the fatal life threatening repetitive ventricular arrhythmias and catecholamine levels during acute thrombolytic phase of myocardial infarction providing the evidence that a proper dose of beta-blocker might further help patients taking Captopril in the early hospitalization phase of the recovery among patients with acute myocardial infarction 8 .
Also Captopril exerts beneficial effect in reducing the number of complex ventricular arrhythmias in postmyocardial ischemic patients accompanied by left ventricular dysfunction, mediated via alterations in left ventricle remodeling 19 . The study positively concludes that
